FindTrial
Sign In

The application value of medical social we-media in initial therapy of radioactive iodine for patients with Graves's disease

The application value of medical social we-media in initial therapy of radioactive iodine for patients with Graves's disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000034111
Enrollment
Unknown
Registered
2020-06-24
Start date
2020-07-01
Completion date
Unknown
Last updated
2020-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyroidism

Interventions

experimental group:Network medical social we-media
control group:Traditional health education

Sponsors

The First Pepole's Hospital of Huaihua City
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The patient's age is more than or equal to 18 years old; 2. Patients diagnosed with Gd less than 4 weeks; 3. Patients who were treated with iodine-131 for the first time without operation; 4. For those patients treated with antithyroid drugs, the course of treatment is no more than 4 weeks and the drugs have been stopped; 5. Patients who can use smart phones correctly.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Patients who have been operated.

Design outcomes

Primary

MeasureTime frame
Clinical compliance;Thyroid disease awareness;—

Secondary

MeasureTime frame
Remission rate of hyperthyroidism;—

Countries

China

Contacts

Public ContactLiu Xue

The First Pepole's Hospital of Huaihua City

517338758@qq.com+86 15874500391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026